Natterman (Dry Extract Of Hederae Folium (5-7.5:1), Extraction Solvent: Ethanol 30% (M/M))

The extract is rich in saponins, especially hederacoside C, which act as expectorants and mild bronchodilators. Saponins stimulate the secretion of watery mucus, improve ciliary activity, and relax bronchial smooth muscle, thereby facilitating clearance of secretions and reducing airway resistance. Anti‑inflammatory constituents may also modulate irritation of the respiratory mucosa.

The specific dose of Natterman is determined by the prescribing healthcare professional based on the patient’s age, condition severity and overall treatment plan. The product is supplied as a standardized dry extract for oral administration, and the prescriber will indicate the appropriate amount and frequency on the prescription label.

Safety data for dry extract of Hederae folium in pregnancy and lactation are limited. Because the risk cannot be ruled out, it is generally advised that pregnant or breastfeeding women only use Natterman if the potential benefit justifies any possible risk and under direct medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Natterman. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other herbal expectorants such as thyme‑based syrups, Natterman’s ivy leaf extract provides a high concentration of saponins that are well‑studied for bronchodilatory and mucolytic activity. While both classes aim to ease cough, ivy leaf may offer a more pronounced smooth‑muscle relaxation, though individual response can vary.

Natterman should be stored at ambient temperature, below 25 °C, in its original packaging. The container should be kept tightly closed, protected from moisture, direct sunlight and excessive heat to preserve the stability of the herbal constituents throughout its shelf life.

Natterman is taken orally as directed by a qualified healthcare professional. The extract is typically provided in a measured dose form such as a capsule or liquid; the patient should follow the prescribed dosage schedule, swallow the dose with water, and avoid crushing or dissolving tablets unless instructed otherwise.

Although generally well tolerated, serious adverse reactions can occur, including severe allergic responses such as anaphylaxis, bronchospasm that worsens breathing difficulty, and rare liver enzyme elevations indicating hepatic stress. Patients should seek immediate medical attention if they experience swelling of the face, throat tightness, sudden breathing problems or jaundice.

Natterman is contraindicated in individuals with known hypersensitivity to ivy leaf or any component of the formulation. It should also be avoided by patients taking anticoagulant therapy without medical supervision, and by those with uncontrolled asthma or severe bronchial hyper‑reactivity until evaluated by a physician.